Anti-inflammatory strategy stops aggressive childhood cancer
Researchers at Karolinska Institutet and Karolinska University Hospital have discovered that an anti-inflammatory drug candidate inhibiting the prostaglandin E2 producing enzyme mPGES-1 in the tumour stroma reduces tumour growth in experimental neuroblastoma models.
Read more: https://medicalxpress.com/news/2018-05-anti-inflammatory-strategy-aggressive-childhood-cancer.html